Paper Details

  1. Home
  2. Paper Details

Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.

Author: Abdel-RaoufSamar M, AbdeldayemHussein Mohammed, ArafaEssa M, AtwaKhalid, GirbashEhab F, NoohAhmed Mohamed

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Depo-Provera (medroxyprogesterone acetate) is an effective and safe treatment for endometrial hyperplasia without atypia. It is more effective than oral norethisterone acetate in achieving regression of nonatypical endometrial hyperplasia.
Paper Details　
Original Abstract of the Article :
The objective of this study was to assess effectiveness and safety of Depo-Provera (medroxyprogesterone acetate) in treatment of endometrial hyperplasia (EH) and to compare it with norethisterone acetate (NETA) as an oral progestogen treatment. One hundred forty six women aged 35 to 50 years with ab...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1933719115623643

データ提供：米国国立医学図書館（NLM）

Comparing Depo-Provera and Norethisterone Acetate for Endometrial Hyperplasia

Endometrial hyperplasia, a condition characterized by the abnormal thickening of the uterine lining, is a common concern for women. This study compares the effectiveness and safety of two progestin treatments for endometrial hyperplasia without atypia: Depo-Provera (medroxyprogesterone acetate) and norethisterone acetate (NETA). The authors conducted a randomized controlled trial to evaluate the efficacy of these treatments in achieving regression of endometrial hyperplasia, assessing both the positive outcomes and potential side effects.

Finding Effective Treatment Options for Endometrial Hyperplasia

The study reveals that Depo-Provera is more effective than NETA in achieving regression of nonatypical endometrial hyperplasia. This finding provides valuable insights for clinicians in choosing the most appropriate treatment option for their patients. This is a significant step forward in understanding the treatment landscape for this common condition.

Navigating the Terrain of Endometrial Hyperplasia Treatment

The study highlights the importance of considering both the effectiveness and safety of treatment options for endometrial hyperplasia. The authors' findings provide valuable information that can help clinicians make informed decisions about the best course of treatment for their patients. This is a journey through the complex terrain of endometrial hyperplasia treatment, where finding the right path can lead to better outcomes for women.

Dr.Camel's Conclusion

This randomized controlled trial provides valuable insights into the treatment of endometrial hyperplasia. The study's findings highlight the effectiveness of Depo-Provera in achieving regression of nonatypical endometrial hyperplasia, offering a promising treatment option for women. This research is like discovering a hidden oasis in the desert of endometrial hyperplasia, providing relief and hope for those seeking effective treatment.

Date :
  1. Date Completed 2017-01-20
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26718306

DOI: Digital Object Identifier

10.1177/1933719115623643

Related Literature

Article Analysis
・Side Effects of norethindrone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.